Hints and tips:
...Before Alere, Mr Nawana spent more than 15 years at Johnson & Johnson, including time as president of its DePuy Synthes spine business....
...Pharmaceutical sales were up 10 per cent to $6.8bn, and medical devices and diagnostics up 10 per cent to $7.1bn, much the result of its acquisition of Synthes....
...William Weldon, head of J&J, says ringingly of the accord: “DePuy and Synthes together will create the most innovative and comprehensive orthopaedics business in the world, and enable us to better serve...
...The UK’s Medicines and Healthcare Products Regulatory Agency, for example, was the first to identify problems with DePuy’s ASR artificial metal hips, triggering recalls in 2009 and 2010....
...A successful bid for Synthes, the Swiss medical device maker, could be timely medicine for Johnson & Johnson after a year plagued by product recalls and bribery allegations....
...Investors and analysts were hoping to learn more about J&J’s takeover talks with Synthes, the Swiss medical device maker that acknowledged on Monday that discussions about a combination were taking place...
International Edition